No jump before earnings; Drop to $30? $25? $20? $Sideways?
Обновлено
Can't get back above 0 on MACD. Can't get back above 50 on Stoch RSI. TradingNewsNow claims an intrinsic value per share above $130. Results and Presentations seem to not be helping. I'd "like" to see 41/share, but 24/share might be more the direction of Nektar Therapeutics before a rebound. Continuing to watch sideways movements between $30-$37 in the meantime.
Not a broker, nor is this financial advice. I had Nektar hope in opioid replacements for pain therapy and immuno-oncology therapies. I guess they simply cannot beat cannabis in providing quality of life.
Not a broker, nor is this financial advice. I had Nektar hope in opioid replacements for pain therapy and immuno-oncology therapies. I guess they simply cannot beat cannabis in providing quality of life.
Сделка активна
Lowered Position
Похожие публикации
Отказ от ответственности
Все виды контента, которые вы можете увидеть на TradingView, не являются финансовыми, инвестиционными, торговыми или любыми другими рекомендациями. Мы не предоставляем советы по покупке и продаже активов. Подробнее — в Условиях использования TradingView.